Zydus Lifesciences Receives USFDA Approval for Generic Prostate Cancer Drug, Biocon Faces USFDA Observations
The US Food and Drug Administration (USFDA) has given Zydus Lifesciences permission to produce a generic version of Enzalutamide
The US Food and Drug Administration (USFDA) has given Zydus Lifesciences permission to produce a generic version of Enzalutamide
During Monday’s trading session on the Bombay Stock Exchange (BSE), Biocon’s shares saw a 2% decline, falling to ₹361.5.
The deputy CEO of the Ayushman Bharat initiative, Dr. Ravi Vimal, was the subject of a corruption probe that
Following the mysterious death of Dr. Kartikeya Srivastava, a 28-year-old Master of Surgery (MS) student at Motilal Nehru Medical
In an effort to enhance healthcare services throughout the state, the Madhya Pradesh government announced on Sunday that it
According to a recent survey conducted by the diagnostics company Healthians, 31% of Indians suffer from excessive cholesterol, with
The cardiology department of the Government Medical College in Thiruvananthapuram successfully completed six unusual cardiac procedures, which was a
Antimicrobial resistance (AMR) is posing an increasing danger to world health and is responsible for around 5 million fatalities
According to a recent study, food packaging and plastic dinnerware contain about 200 chemicals that have been related to
Healthcare expenses in India are rising at a worrying rate of 14% year, according to the ACKO India Health
Copyright © 2024 Medipreneurx. All rights reserved.